Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1984 1
1985 2
1986 2
1991 2
1992 2
1994 1
1996 3
1998 7
1999 2
2000 3
2001 3
2002 6
2003 4
2004 6
2005 4
2006 2
2007 4
2008 5
2009 4
2010 6
2011 14
2012 3
2013 8
2014 9
2015 4
2016 7
2017 4
2018 7
2019 6
2020 8
2021 15
2022 5
2023 6
2024 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

156 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for bertolotto c[au]
Your search for Bertoletto C[au] retrieved no results
Melanoma models for the next generation of therapies.
Patton EE, Mueller KL, Adams DJ, Anandasabapathy N, Aplin AE, Bertolotto C, Bosenberg M, Ceol CJ, Burd CE, Chi P, Herlyn M, Holmen SL, Karreth FA, Kaufman CK, Khan S, Kobold S, Leucci E, Levy C, Lombard DB, Lund AW, Marie KL, Marine JC, Marais R, McMahon M, Robles-Espinoza CD, Ronai ZA, Samuels Y, Soengas MS, Villanueva J, Weeraratna AT, White RM, Yeh I, Zhu J, Zon LI, Hurlbert MS, Merlino G. Patton EE, et al. Among authors: bertolotto c. Cancer Cell. 2021 May 10;39(5):610-631. doi: 10.1016/j.ccell.2021.01.011. Epub 2021 Feb 4. Cancer Cell. 2021. PMID: 33545064 Free PMC article. Review.
Super-enhancer-driven expression of BAHCC1 promotes melanoma cell proliferation and genome stability.
Berico P, Nogaret M, Cigrang M, Lallement A, Vand-Rajabpour F, Flores-Yanke A, Gambi G, Davidson G, Seno L, Obid J, Vokshi BH, Le Gras S, Mengus G, Ye T, Cordero CF, Dalmasso M, Compe E, Bertolotto C, Hernando E, Davidson I, Coin F. Berico P, et al. Among authors: bertolotto c. Cell Rep. 2023 Nov 28;42(11):113363. doi: 10.1016/j.celrep.2023.113363. Epub 2023 Nov 3. Cell Rep. 2023. PMID: 37924516 Free article.
LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.
Proteau S, Krossa I, Husser C, Guéguinou M, Sella F, Bille K, Irondelle M, Dalmasso M, Barouillet T, Cheli Y, Pisibon C, Arrighi N, Nahon-Estève S, Martel A, Gastaud L, Lassalle S, Mignen O, Brest P, Mazure NM, Bost F, Baillif S, Landreville S, Turcotte S, Hasson D, Carcamo S, Vandier C, Bernstein E, Yvan-Charvet L, Levesque MP, Ballotti R, Bertolotto C, Strub T. Proteau S, et al. Among authors: bertolotto c. EMBO Mol Med. 2023 Dec 7;15(12):e17719. doi: 10.15252/emmm.202317719. Epub 2023 Nov 15. EMBO Mol Med. 2023. PMID: 37966164 Free PMC article.
Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease.
Pandiani C, Strub T, Nottet N, Cheli Y, Gambi G, Bille K, Husser C, Dalmasso M, Béranger G, Lassalle S, Magnone V, Pédeutour F, Irondelle M, Maschi C, Nahon-Estève S, Martel A, Caujolle JP, Hofman P, LeBrigand K, Davidson I, Baillif S, Barbry P, Ballotti R, Bertolotto C. Pandiani C, et al. Among authors: bertolotto c. Cell Death Differ. 2021 Jun;28(6):1990-2000. doi: 10.1038/s41418-020-00730-7. Epub 2021 Jan 18. Cell Death Differ. 2021. PMID: 33462406 Free PMC article.
Cholesterol efflux pathways hinder KRAS-driven lung tumor progenitor cell expansion.
Guilbaud E, Barouillet T, Ilie M, Borowczyk C, Ivanov S, Sarrazy V, Vaillant N, Ayrault M, Castiglione A, Rignol G, Brest P, Bazioti V, Zaitsev K, Lebrigand K, Dussaud S, Magnone V, Bertolotto C, Marchetti S, Irondelle M, Goldberg I, Huby T, Westerterp M, Gautier EL, Mari B, Barbry P, Hofman P, Yvan-Charvet L. Guilbaud E, et al. Among authors: bertolotto c. Cell Stem Cell. 2023 Jun 1;30(6):800-817.e9. doi: 10.1016/j.stem.2023.05.005. Cell Stem Cell. 2023. PMID: 37267915 Free article.
Focus on cutaneous and uveal melanoma specificities.
Pandiani C, Béranger GE, Leclerc J, Ballotti R, Bertolotto C. Pandiani C, et al. Among authors: bertolotto c. Genes Dev. 2017 Apr 15;31(8):724-743. doi: 10.1101/gad.296962.117. Genes Dev. 2017. PMID: 28512236 Free PMC article. Review.
Orbital exenteration: an updated review with perspectives.
Martel A, Baillif S, Nahon-Esteve S, Gastaud L, Bertolotto C, Lassalle S, Lagier J, Hamedani M, Poissonnet G. Martel A, et al. Among authors: bertolotto c. Surv Ophthalmol. 2021 Sep-Oct;66(5):856-876. doi: 10.1016/j.survophthal.2021.01.008. Epub 2021 Jan 29. Surv Ophthalmol. 2021. PMID: 33524457 Review.
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma.
Di Leo L, Pagliuca C, Kishk A, Rizza S, Tsiavou C, Pecorari C, Dahl C, Pacheco MP, Tholstrup R, Brewer JR, Berico P, Hernando E, Cecconi F, Ballotti R, Bertolotto C, Filomeni G, Gjerstorff MF, Sauter T, Lovat P, Guldberg P, De Zio D. Di Leo L, et al. Among authors: bertolotto c. Proc Natl Acad Sci U S A. 2024 Jun 18;121(25):e2400566121. doi: 10.1073/pnas.2400566121. Epub 2024 Jun 13. Proc Natl Acad Sci U S A. 2024. PMID: 38870061
Recent advances in understanding the role of HES6 in cancers.
Krossa I, Strub T, Martel A, Nahon-Esteve S, Lassalle S, Hofman P, Baillif S, Ballotti R, Bertolotto C. Krossa I, et al. Among authors: bertolotto c. Theranostics. 2022 May 20;12(9):4374-4385. doi: 10.7150/thno.72966. eCollection 2022. Theranostics. 2022. PMID: 35673577 Free PMC article. Review.
Lysine Methyltransferase NSD1 and Cancers: Any Role in Melanoma?
Krossa I, Strub T, Aplin AE, Ballotti R, Bertolotto C. Krossa I, et al. Among authors: bertolotto c. Cancers (Basel). 2022 Oct 5;14(19):4865. doi: 10.3390/cancers14194865. Cancers (Basel). 2022. PMID: 36230787 Free PMC article. Review.
156 results